Acute Porphyria Drug Database

Monograph

B06AB - Heme Products
Not porphyrinogenic
NP

Rationale
Organic compound known to be of benefit in acute porphyria.
Chemical description
Heme arginate used in treatment of the acute porphyric attack.

Similar drugs
Explore alternative drugs in similar therapeutic classes B06A / B06AB or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Normosang · Normosang 25 mg/ml sol. perf. (à diluer) i.v. amp.
Poland
Human Hemin Orphan Europe
Luxembourg
NORMOSANG
Iceland
Normosang
Latvia
Normosang
Serbia
Normosang · Normosang®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙